Is zinc deficiency a risk factor for atherosclerosis?

British Journal of Nutrition

Volumn 91, Issue 2, 2004, Pages 177-181

  Beattie, John H ^a   Kwun, In Sook ^b  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b Andong National University   (South Korea)

Author keywords

Atherosclerosis; Metallothionein; Zinc

Indexed keywords

CASPASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; ZINC; ZINC FINGER PROTEIN;

ANIMAL MODEL; APOPTOSIS; ARTERIOSCLEROSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; DISEASE ASSOCIATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; INCIDENCE; INTRACELLULAR SPACE; ISCHEMIC HEART DISEASE; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; NUTRITIONAL DEFICIENCY; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; OXIDATIVE STRESS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN FUNCTION; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SIGNAL PROCESSING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; ZINC DEFICIENCY;

ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; RISK FACTORS; SIGNAL TRANSDUCTION; ZINC;

ANIMALIA;

EID: 1442331981     PISSN: 00071145     EISSN: None     Source Type: Journal    
DOI: 10.1079/BJN20031072     Document Type: Article

References (56)

1. Alissa EM, Bahijri SM & Ferns GA (2003) The controversy surrounding selenium and cardiovascular disease: a review of the evidence. Med Sci Monit 9, RA9-RA18.
2. Anderson TJ (2003) Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction. Heart Fail Rev 8, 71-86.
3. Ball MJ & Ackland ML (2000) Zinc intake and status in Australian vegetarians. Br J Nutr 83, 27-33.
4. Bannon P, James N & Jessup W (2003) The endothelial cell in atherosclerosis. In Atherosclerosis: Gene Expression, Cell Interactions and Oxidation, pp. 137-158 [RT Dean and DT Kelly, editors]. Oxford: Oxford University Press.
5. Bao B, Prasad AS, Beck FWJ & Godmere M (2003) Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab 285, E1095-E1102.
6. Berendji D, Kolb-Bachofen V, Meyer KL, Grapenthin O, Weber H, Wahn V & Kroncke KD (1997) Nitric oxide mediates intracytoplasmic and intranuclear zinc release. FEBS Lett 405, 37-41.
7. Carey LC, Coyle P, Philcox JC & Rofe AM (2000) Ethanol decreases zinc transfer to the fetus in normal but not metallothionein-null mice. Alcohol Clin Exp Res 24, 1236-1240.
8. Chesters JK (1997) Zinc. In Handbook of Nutritionally Essential Mineral Elements, pp. 185-230 [BL O'Dell and RA Sunde, editors]. New York: Marcel Dekker Inc.
9. Coleman JE (1992) Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem 61, 897-946, 897-946.
10. De Martin R, Hoeth M, Hofer-Warbinek R & Schmid JA (2000) The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol 20, E83-E88.
11. Duvall E & Wyllie AH (1986) Death and the cell. Immunol Today 7, 115-119.
12. Fanzo JC, Reaves SK, Cui L, Zhu L & Lei KY (2002) p53 Protein and p21 mRNA levels and caspase-3 activity are altered by zinc status in aortic endothelial cells. Am J Physiol 283, C631-C638.
13. Geng YJ (2001) Molecular signal transduction in vascular cell apoptosis. Cell Res 11, 253-264.
14. Gow A & Ischiropoulos H (2002) NO running on MT: regulation of zinc homeostasis by interaction of nitric oxide with metallothionein. Am J Physiol Lung Cell Mol Physiol 282, L183-L184.
15. Haase H & Beyersmann D (2002) Intracellular zinc distribution and transport in C6 rat glioma cells. Biochem Biophys Res Commun 296, 923-928.
16. Hainaut P & Mann K (2001) Zinc binding and redox control of p53 structure and function. Antioxid Redox Signal 3, 611-623.
17. Hambidge M (2000) Human zinc deficiency. J Nutr 130, 1344S-1349S.
18. Hambidge M (2003) Biomarkers of trace mineral intake and status. J Nutr 133, Suppl. 3, 948S-955S.
19. Hambidge M & Krebs NF (2001) Interrelationships of key variables of human zinc homeostasis: relevance to dietary zinc requirements. Annu Rev Nutr 21, 429-452.
20. Hennig B, Meerarani P, Ramadass P, Toborek M, Malecki A, Slim R & McClain CJ (1999b) Zinc nutrition and apoptosis of vascular endothelial cells: implications in atherosclerosis. Nutrition 15, 744-748.
21. Hennig B, Meerarani P, Toborek M & McClain CJ (1999a) Antioxidant-like properties of zinc in activated endothelial cells. Am J Coll Nutr 18, 152-158.
22. Hennig B, Toborek M & McClain CJ (1996) Antiatherogenic properties of zinc: implications in endothelial cell metabolism. Nutrition 12, 711-717.
23. Hotz C, Peerson JM & Brown KH (2003) Suggested lower cutoffs of serum zinc concentrations for assessing zinc status: reanalysis of the second National Health and Nutrition Examination Survey data (1976-1980). Am J Clin Nutr 78, 756-764.
24. Kim CH, Kim JH, Moon SJ, Chung KC, Hsu CY, Seo JT & Ahn YS (1999) Pyrithione, a zinc ionophore, inhibits NF-kappaB activation. Biochem Biophys Res Commun 259, 505-509.
25. King JC, Shames DM & Woodhouse LR (2000) Zinc homeostasis in humans. J Nutr 130, 1360S-1366S.
26. Kohrl J, Brigelius-Flohe R, Bock A, Gartner R, Meyer O & Flohe L (2000) Selenium in biology: facts and medical perspectives. Biol Chem 381, 849-864.
27. Kok FJ, Van Duijn CM, Hofman A, Van der Voet GB, De Wolff FA, Paays CH & Valkenburg HA (1988) Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am J Epidemiol 128, 352-359.
28. Kroncke KD, Fehsel K, Schmidt T, Zenke FT, Dasting I, Wesener JR, Bettermann H, Breunig KD & Kolb-Bachofen V (1994) Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem Biophys Res Commun 200, 1105-1110.
29. Kudrin AV (2000) Trace elements in regulation of NF-kappaB activity. J Trace Elem Med Biol 14, 129-142.
30. Lentner C (editor) (1984) Geigy Scientific Tables, vol. 3. Basle: Ciba-Geigy Ltd.
31. Lichtlen P & Schaffner W (2001) The "metal transcription factor" MTF-1: biological facts and medical implications. Swiss Med Wkly 131, 647-652.
32. 70Zn. Clin Sci (Lond) 84, 113-117.
33. Maret W, Jacob C, Vallee BL & Fischer EH (1999) Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc Natl Acad Sci USA 96, 1936-1940.
34. May MJ & Ghosh S (1998) Signal transduction through NF-kappa B. Immunol Today 19, 80-88.
35. Meerarani P, Ramadass P, Toborek M, Bauer HC, Bauer H & Hennig B (2000) Zinc protects against apoptosis of endothelial cells induced by linoleic acid and tumor necrosis factor alpha. Am J Clin Nutr 71, 81-87.
36. Miles AT, Hawksworth GM, Beattie JH & Rodilla V (2000) Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit Rev Biochem Mol Biol 35, 35-70.
37. Outten CE & O'Halloran TV (2001) Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis. Science 292, 2488-2492.
38. Pearce LL, Gandley RE, Han W, Wasserloos K, Stitt M, Kanai AJ, McLaughlin MK, Pitt BR & Levitan ES (2000a) Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein. Proc Natl Acad Sci USA 97, 477-482.
39. Pearce LL, Wasserloos K, St Croix M, Gandley R, Levitan ES & Pitt BR (2000b) Metallothionein, nitric oxide and zinc homeostasis in vascular endothelial cells. J Nutr 130, 1467S-1470S.
40. Perry DK, Smyth MJ, Stennicke HR, Salvesen GS, Duriez P, Poirier GG & Hannun YA (1997) Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J Biol Chem 272, 18530-18533.
41. Philcox JC, Coyle P, Michalska A, Choo KH & Rote AM (1995) Endotoxin-induced inflammation does not cause hepatic zinc accumulation in mice lacking metallothionein gene expression. Biochem J 308, 543-546.
42. Powell SR (2000) The antioxidant properties of zinc. J Nutr 130, 1447S-1454S.
43. Prasad AS, Bao B, Beck FW & Sarkar FH (2002) Zinc enhances the expression of interleukin-2 and interleukin-2 receptors in HUT-78 cells by way of NF-kappaB activation. J Lab Clin Med 140, 272-289.
44. Prasad AS, Fitzgerald JT, Hess JW, Kaplan J, Pelen F & Dardenne M (1993) Zinc deficiency in elderly patients. Nutrition 9, 218-224.
45. Rowe DJ & Bobilya DJ (2000) Albumin facilitates zinc acquisition by endothelial cells. Proc Soc Exp Biol Med 224, 178-186.
46. St Croix CM, Wasserloos KJ, Dineley KE, Reynolds JJ & Pitt BR (2002) Nitric oxide-inducing changes in intracellular zinc homeostasis are mediated by metallothionein/thionein. Am J Physiol Lung Cell Mol Physiol 282, L185-L192.
47. Strain JJ (1998) Trace elements and cardiovascular disease. Bibl Nutr Dieta 127-140.
48. Truong-Tran AQ, Carter J, Ruffin RE & Zalewski PD (2001) The role of zinc in caspase activation and apoptotic cell death. Biometals 14, 315-330.
49. Truong-Tran AQ, Ho LH, Chai F & Zalewski PD (2000) Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. J Nutr 130, 1459S-1466S.
50. Tunstall-Pedoe H (editor) (2003) Monica Monograph and Multimedia Sourcebook: World's Largest Study of Heart Disease, Stroke, Risk Factors and Population Trends 1979-2002. Geneva: WHO.
51. Vallee BL & Falchuk KH (1993) The biochemical basis of zinc physiology. Physiol Rev 73, 79-118.
52. Webster KA, Prentice H & Bishopric NH (2001) Oxidation of zinc finger transcription factors: physiological consequences. Antioxid Redox Signal 3, 535-548.
53. World Health Organisation (2002) Quantifying selected major risks to health. In The World Health Report 2002. Geneva: WHO.
54. Wilkins GM & Leake DS (1994) The oxidation of low density lipoprotein by cells or iron is inhibited by zinc. FEBS Lett 341, 259-262.
55. Yancy WS, Westman EC, French PA & Califf RM (2003) Diets and clinical coronary events: the truth is out there. Circulation 107, 10-46.
56. Zou MH, Shi C & Cohen RA (2002) Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109, 817-826.